These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3395481

  • 1. An experimental model system for leishmaniasis. Effects of porphyrin-compounds and menadione on Leishmania parasites engulfed by cultured macrophages.
    Abok K, Cadenas E, Brunk U.
    APMIS; 1988 Jun; 96(6):543-51. PubMed ID: 3395481
    [Abstract] [Full Text] [Related]

  • 2. An experimental model system for leishmaniasis. An ultrastructural study on cultured macrophages exposed to Leishmania parasites and sodium stibogluconate.
    Abok K, Fredriksson BA, Brunk U.
    APMIS; 1988 Jul; 96(7):589-95. PubMed ID: 2841954
    [Abstract] [Full Text] [Related]

  • 3. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
    Reiner NE.
    J Immunol; 1987 Mar 15; 138(6):1919-25. PubMed ID: 3493291
    [Abstract] [Full Text] [Related]

  • 4. Amphotericin B inhibits entry of Leishmania donovani into primary macrophages.
    Paila YD, Saha B, Chattopadhyay A.
    Biochem Biophys Res Commun; 2010 Aug 27; 399(3):429-33. PubMed ID: 20678487
    [Abstract] [Full Text] [Related]

  • 5. Intracellular destruction of Leishmania donovani and Leishmania tropica amastigotes by activated macrophages: dissociation of these microbicidal effector activities in vitro.
    Hockmeyer WT, Walters D, Gore RW, Williams JS, Fortier AH, Nacy CA.
    J Immunol; 1984 Jun 27; 132(6):3120-5. PubMed ID: 6725948
    [Abstract] [Full Text] [Related]

  • 6. Potential of doxorubicin as an antileishmanial agent.
    Sett R, Basu N, Ghosh AK, Das PK.
    J Parasitol; 1992 Apr 27; 78(2):350-4. PubMed ID: 1556650
    [Abstract] [Full Text] [Related]

  • 7. Antiparasitic activity of a triphenyl tin complex against Leishmania donovani.
    Raychaudhury B, Banerjee S, Gupta S, Singh RV, Datta SC.
    Acta Trop; 2005 Jul 27; 95(1):1-8. PubMed ID: 15896700
    [Abstract] [Full Text] [Related]

  • 8. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
    Sarkar K, Das PK.
    J Immunol; 1997 Jun 01; 158(11):5357-65. PubMed ID: 9164956
    [Abstract] [Full Text] [Related]

  • 9. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
    Everlien H, Hockertz S.
    Arzneimittelforschung; 1999 Nov 01; 49(11):954-61. PubMed ID: 10604050
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent.
    Seifert K, Escobar P, Croft SL.
    J Antimicrob Chemother; 2010 Mar 01; 65(3):508-11. PubMed ID: 20089542
    [Abstract] [Full Text] [Related]

  • 11. A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages.
    Channon JY, Roberts MB, Blackwell JM.
    Immunology; 1984 Oct 01; 53(2):345-55. PubMed ID: 6490087
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of leishmanicidal activity of human macrophages against Leishmania major and Leishmania donovani infection using recombinant human granulocyte macrophage colony stimulating factor.
    Al-Zamel F, Al-Shammary FJ, El-Shewemi S, Soliman R.
    Zentralbl Bakteriol; 1996 Sep 01; 285(1):92-105. PubMed ID: 8946701
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of human beta-casein fragment (54-59) and its synthetic analogue compound 89/215 against Leishmania donovani in hamsters.
    Sharma P, Singh N, Garg R, Haq W, Dube A.
    Peptides; 2004 Nov 01; 25(11):1873-81. PubMed ID: 15501518
    [Abstract] [Full Text] [Related]

  • 14. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I, Rougier S, Dugas B, Pino P, Mazier D, Woehrlé F.
    Vet Parasitol; 2006 Jan 30; 135(2):137-46. PubMed ID: 16242844
    [Abstract] [Full Text] [Related]

  • 15. Differential survival of Leishmania donovani amastigotes in human monocytes.
    Pearson RD, Harcus JL, Roberts D, Donowitz GR.
    J Immunol; 1983 Oct 30; 131(4):1994-9. PubMed ID: 6619546
    [Abstract] [Full Text] [Related]

  • 16. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
    Sharief AH, Gasim Khalil EA, Theander TG, Kharazmi A, Omer SA, Ibrahim ME.
    Exp Parasitol; 2006 Dec 30; 114(4):247-52. PubMed ID: 16716301
    [Abstract] [Full Text] [Related]

  • 17. Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction.
    Moore KJ, Labrecque S, Matlashewski G.
    J Immunol; 1993 May 15; 150(10):4457-65. PubMed ID: 8482844
    [Abstract] [Full Text] [Related]

  • 18. The sterol-binding antibiotic nystatin inhibits entry of non-opsonized Leishmania donovani into macrophages.
    Tewary P, Veena K, Pucadyil TJ, Chattopadhyay A, Madhubala R.
    Biochem Biophys Res Commun; 2006 Jan 13; 339(2):661-6. PubMed ID: 16310160
    [Abstract] [Full Text] [Related]

  • 19. Arachidonic acid metabolism by murine peritoneal macrophages infected with Leishmania donovani: in vitro evidence for parasite-induced alterations in cyclooxygenase and lipoxygenase pathways.
    Reiner NE, Malemud CJ.
    J Immunol; 1985 Jan 13; 134(1):556-63. PubMed ID: 3917283
    [Abstract] [Full Text] [Related]

  • 20. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E, Lang T, Glaichenhaus N, Antoine JC.
    J Immunol; 1996 Jun 01; 156(11):4318-27. PubMed ID: 8666803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.